Skip to content

A clinical trial to study the effect of Indravaruni Yoga & Mulaka Taila in the management of osteoarthritis of knee joint

A clinical study of Indravaruni Yoga & Mulaka Taila in degenerative Osteoarthritis W.S.R. of Sandhigata Vata

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022622
Enrollment
40
Registered
2020-01-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: 1.Indravaruni Yoga with Mulaka Taila orally 2.Indravaruni Yoga per oral with Mulaka Taila for Local Application: 1.Indravaruni Yoga with lukewarm water 3 gm /BD after meal for 8 weeks

Sponsors

Govt Dhanwantari Ayurvedic College and Hospital Ujjian
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients Presenting with Classical sign and Symptoms of Sandhigata Vata

Exclusion criteria

Exclusion criteria: Patients below 40 year and above 70 years of age Pregnant women and lactating women Associated with Trauma Associated with other systemic or metabolic disorder

Design outcomes

Primary

MeasureTime frame
Change in classical sign & symptoms of Sandhigata vata (At the time of baseline & at the end of the treatment)Timepoint: Total study period 12 months Treatment period 2 months

Secondary

MeasureTime frame
Change in physical function domain Change in K L grading score( At the time of baseline & at the end of the treatment ) Assessment of change in the clinical parameters (on 0,15th,30th,45th and 60th day) Timepoint: Total study period 12 months Treatment period 2 months

Countries

India

Contacts

Public ContactDR NARESH JAIN

Govt Dhanwantri Ayurvedic medical college and hospital

nareshjainujn@gmail.com9826064756

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026